Cargando…

Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma

Adoptive cell therapy using TCR-engineered T cells (TCR-T cells) represents a promising strategy for treating relapsed and metastatic cancers. We previously established methods to identify neoantigen-specific TCRs based on patients’ PBMCs. However, in clinical practice isolation of PBMCs from advanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Teng, Leisegang, Matthias, Xia, Ming, Kiyotani, Kazuma, Li, Ning, Zeng, Chenquan, Deng, Chunyan, Jiang, Jinxing, Harada, Makiko, Agrawal, Nishant, Li, Liangping, Qi, Hui, Nakamura, Yusuke, Ren, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158031/ https://www.ncbi.nlm.nih.gov/pubmed/34104546 http://dx.doi.org/10.1080/2162402X.2021.1929726

Ejemplares similares

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
por: Kato, Taigo, et al.
Publicado: (2018)

Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3
por: Tate, Tomohiro, et al.
Publicado: (2023)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

Neoantigens elicit T cell responses in breast cancer
por: Morisaki, Takafumi, et al.
Publicado: (2021)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy
por: Okamura, Kazumi, et al.
Publicado: (2022)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021)

Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer
por: Ren, Lili, et al.
Publicado: (2017)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
por: Morisaki, Shinji, et al.
Publicado: (2023)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2016)

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
por: Kiyotani, Kazuma, et al.
Publicado: (2020)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
por: Kast, Florian, et al.
Publicado: (2021)

Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
por: Huang, Ruichen, et al.
Publicado: (2023)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
por: Lu, Dan, et al.
Publicado: (2023)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2017)

Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma
por: Schutt, Charles R., et al.
Publicado: (2021)

Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
por: Minegishi, Yuriko, et al.
Publicado: (2022)

Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021)

Rapid generation of genetically engineered T cells for the treatment of virus‐related cancers
por: Jiang, Jinxing, et al.
Publicado: (2022)

The Ways of Isolating Neoantigen-Specific T Cells
por: Li, Qing, et al.
Publicado: (2020)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
por: Nguyen, Kim Bich, et al.
Publicado: (2023)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

Highly clonal regulatory T-cell population in follicular lymphoma – inverse correlation with the diversity of CD8(+) T cells
por: Liu, Xiao, et al.
Publicado: (2015)

Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors
por: Kiyotani, Kazuma, et al.
Publicado: (2017)

Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors
por: Nakakido, Makoto, et al.
Publicado: (2016)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2021)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens
por: Zhou, Wei-Jun, et al.
Publicado: (2019)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022)

Neoantigens and NK Cells: “Trick or Treat” the Cancers?
por: Lv, Dan, et al.
Publicado: (2022)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19
por: Toyoshima, Yujiro, et al.
Publicado: (2020)

Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer
por: Robertson, Jane, et al.
Publicado: (2019)

Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer
por: TAMURA, KENJI, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3p0j8jca6hb00m9c17hc1rvtni